Claus Egstrand appointed new CEO of Enzymatica
The Board of Directors of Enzymatica has appointed Claus Egstrand, the company’s Chief Operating Officer, as CEO of Enzymatica. Claus Egstrand assumes his new position at the latest on January 1, 2022 and succeeds acting CEO Therese Filmersson, who returns to the role as CFO. Claus Egstrand has a long experience from pharmaceutical and medtech companies, such as Merck & Co, Pfizer, Stryker Corporation, Pharmacia, and Johnson&Johnson/Merck Pharmaceuticals.Claus Egstrand joined Enzymatica in 2017 as Chief Commercial Officer, and he was later appointed Chief Operating Officer. Claus Egstrand’s